The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms

by Dahele, Max, Senan, Suresh
Published 2011

A critical review of recent developments in radiotherapy for non-small cell lung cancer

by Baker, Sarah, Dahele, Max, Lagerwaard, Frank J., Senan, Suresh
Published 2016

Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans?

by Tol, Jim P., Dahele, Max, Delaney, Alexander R., Slotman, Ben J., Verbakel, Wilko F. A. R.
Published 2015

Automatic interactive optimization for volumetric modulated arc therapy planning

by Tol, Jim P, Dahele, Max, Peltola, Jarkko, Nord, Janne, Slotman, Ben J, Verbakel, Wilko FAR
Published 2015

Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy

by Taremi, Mojgan, Hope, Andrew, Lindsay, Patricia, Dahele, Max, Fung, Sharon, Purdie, Thomas G, Jaffray, David, Dawson, Laura, Bezjak, Andrea
Published 2012

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

by Palma, David A, Haasbeek, Cornelis J A, Rodrigues, George B, Dahele, Max, Lock, Michael, Yaremko, Brian, Olson, Robert, Liu, Mitchell, Panarotto, Jason, Griffioen, GwendolynHMJ, Gaede, Stewart, Slotman, Ben, Senan, Suresh
Published 2012